Therefore:  a) If a Laboratory  is requested to report an Adverse Analytical Finding (s) for a Sample (s) before all analyses on that Sample  have been completed, then the Laboratory  shall advise the Testing  Authority  or Results Management Authority  (if different) that Sample  analysis has not been completed and, in addition, that if the Athlete  is charged with a Code  Article  2.1 anti -doping rule violation before the additional analys es on the Sample  have been completed, then the additional analys es cannot be conducted until consent from the  Athlete  or approval from a hearing body is obtained ;  b) If the Laboratory  receives a request to conduct Confirmation Procedures  for an atypical or suspicious steroid profile  of a Sample , which are triggered by ADAMS  notifications after the “A” Sample  has already been reported as an Adverse Analytical Finding , then the Laboratory  shall advise the Testing  Authority  or Results Management  Authority  (if different) that if the Athlete  is charged with a Code  Article  2.1 anti -doping  rule violation, the additional Confirmation Procedures  cannot be performed until consent from the Athlete  or approval from a hearing body is obtained.